Emanuela Salvatorelli

5.7k total citations · 1 hit paper
56 papers, 4.7k citations indexed

About

Emanuela Salvatorelli is a scholar working on Cardiology and Cardiovascular Medicine, Oncology and Biophysics. According to data from OpenAlex, Emanuela Salvatorelli has authored 56 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Cardiology and Cardiovascular Medicine, 32 papers in Oncology and 17 papers in Biophysics. Recurrent topics in Emanuela Salvatorelli's work include Chemotherapy-induced cardiotoxicity and mitigation (42 papers), Cancer Treatment and Pharmacology (26 papers) and Electron Spin Resonance Studies (17 papers). Emanuela Salvatorelli is often cited by papers focused on Chemotherapy-induced cardiotoxicity and mitigation (42 papers), Cancer Treatment and Pharmacology (26 papers) and Electron Spin Resonance Studies (17 papers). Emanuela Salvatorelli collaborates with scholars based in Italy, United States and Malaysia. Emanuela Salvatorelli's co-authors include Giorgio Minotti, Pierantonio Menna, Luca Gianni, Gaetano Cairo, Elvio Covino, Massimo Chello, Odalys Gonzalez Paz, Raffaella Ronchi, Antonio M. Calafiore and Gianfranca Corna and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Pharmacological Reviews.

In The Last Decade

Emanuela Salvatorelli

55 papers receiving 4.6k citations

Hit Papers

Anthracyclines: Molecular Advances and Pharmacologic Deve... 2004 2026 2011 2018 2004 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
    2004 3.0k citations Giorgio Minotti, Pierantonio Menna et al. Pharmacological Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emanuela Salvatorelli Italy 23 2.3k 1.7k 1.5k 543 454 56 4.7k
Pierantonio Menna Italy 25 2.4k 1.0× 1.8k 1.0× 1.6k 1.0× 548 1.0× 477 1.1× 65 4.8k
Srigiridhar Kotamraju India 37 941 0.4× 686 0.4× 2.4k 1.6× 204 0.4× 322 0.7× 82 5.3k
Tomáš Šimůnek Czechia 33 1.5k 0.7× 877 0.5× 826 0.5× 93 0.2× 282 0.6× 93 3.4k
Eugene A. Konorev United States 26 1.1k 0.5× 529 0.3× 1.4k 0.9× 182 0.3× 420 0.9× 42 3.2k
Elena Monti Italy 35 418 0.2× 1.2k 0.7× 1.1k 0.7× 152 0.3× 312 0.7× 119 3.5k
Nicholas R. Bachur United States 35 1.3k 0.5× 1.5k 0.9× 1.8k 1.2× 99 0.2× 425 0.9× 96 4.6k
Jing Lü China 41 458 0.2× 1.3k 0.7× 4.5k 3.0× 156 0.3× 64 0.1× 189 6.8k
Karen R. Grotzinger United States 13 566 0.2× 1.2k 0.7× 1.6k 1.0× 89 0.2× 230 0.5× 18 3.3k
Graziella Pratesi Italy 42 328 0.1× 3.9k 2.2× 3.7k 2.4× 197 0.4× 71 0.2× 147 6.7k
Rosanna Supino Italy 37 175 0.1× 1.7k 1.0× 3.0k 2.0× 158 0.3× 131 0.3× 109 4.9k

Countries citing papers authored by Emanuela Salvatorelli

Since Specialization
Citations

This map shows the geographic impact of Emanuela Salvatorelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emanuela Salvatorelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emanuela Salvatorelli more than expected).

Fields of papers citing papers by Emanuela Salvatorelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emanuela Salvatorelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emanuela Salvatorelli. The network helps show where Emanuela Salvatorelli may publish in the future.

Co-authorship network of co-authors of Emanuela Salvatorelli

This figure shows the co-authorship network connecting the top 25 collaborators of Emanuela Salvatorelli. A scholar is included among the top collaborators of Emanuela Salvatorelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emanuela Salvatorelli. Emanuela Salvatorelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Minotti, Giorgio, Massimiliano Camilli, Emanuela Salvatorelli, & Pierantonio Menna. (2025). Advances in Bruton tyrosine kinase (Btk) inhibition are steered by Bruton tyrosine kinase phylogeny. British Journal of Pharmacology. 182(7). 1446–1451.
2.
Camilli, Massimiliano, et al.. (2024). Anthracyclines, Diastolic Dysfunction and the road to Heart Failure in Cancer survivors: An untold story. Progress in Cardiovascular Diseases. 86. 38–47. 5 indexed citations
3.
Menna, Pierantonio, Francesco Marchesi, Chiara Cattaneo, et al.. (2023). Posaconazole and midostaurin in patients with FLT3‐mutated acute myeloid leukemia: Pharmacokinetic interactions and clinical facts in a real life study. Clinical and Translational Science. 16(10). 1876–1885. 3 indexed citations
4.
Salvatorelli, Emanuela, Giorgio Minotti, & Pierantonio Menna. (2023). New Targeted Drugs for Acute Myeloid Leukemia and Antifungals: Pharmacokinetic Challenges and Opportunities. Chemotherapy. 68(3). 170–182. 2 indexed citations
5.
Menna, Pierantonio, Emanuela Salvatorelli, Maria Ilaria Del Principe, et al.. (2021). Choosing Antifungals for the Midostaurin-Treated Patient: Does CYP3A4 Outweigh Recommendations? A Brief Insight from Real Life. Chemotherapy. 66(1-2). 47–52. 9 indexed citations
6.
Menna, Pierantonio, Ugo de Grazia, Francesco Marchesi, Giorgio Minotti, & Emanuela Salvatorelli. (2020). Further Analytical, Pharmacokinetic, and Clinical Observations on Low-Dose Ponatinib in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia. Chemotherapy. 65(1-2). 35–41. 2 indexed citations
7.
Marchesi, Francesco, Emanuela Salvatorelli, Daniela Renzi, et al.. (2019). Efficacy and safety of low dose ponatinib in a case of Ph‐positive acute lymphoblastic leukaemia. British Journal of Haematology. 187(1). e15–e17. 6 indexed citations
8.
Marchesi, Francesco, Corrado Girmenia, Bianca Maria Goffredo, et al.. (2018). Isavuconazole: Case Report and Pharmacokinetic Considerations. Chemotherapy. 63(5). 253–256. 7 indexed citations
9.
Menna, Pierantonio & Emanuela Salvatorelli. (2017). Primary Prevention Strategies for Anthracycline Cardiotoxicity: A Brief Overview. Chemotherapy. 62(3). 159–168. 65 indexed citations
10.
Menna, Pierantonio, et al.. (2017). Modified Colistin Regimen for Critically Ill Patients with Acute Renal Impairment and Continuous Renal Replacement Therapy. Chemotherapy. 63(1). 35–38. 10 indexed citations
11.
Cacciapaglia, Fabio, Emanuela Salvatorelli, Giorgio Minotti, Antonella Afeltra, & Pierantonio Menna. (2014). Low Level Tumor Necrosis Factor-Alpha Protects Cardiomyocytes Against High Level Tumor Necrosis Factor-Alpha: Brief Insight into a Beneficial Paradox. Cardiovascular Toxicology. 14(4). 387–392. 6 indexed citations
12.
Salvatorelli, Emanuela, Pierantonio Menna, Odalys Gonzalez Paz, et al.. (2012). Pharmacokinetic Characterization of Amrubicin Cardiac Safety in an Ex Vivo Human Myocardial Strip Model. II. Amrubicin Shows Metabolic Advantages over Doxorubicin and Epirubicin. Journal of Pharmacology and Experimental Therapeutics. 341(2). 474–483. 28 indexed citations
13.
Salvatorelli, Emanuela, Pierantonio Menna, Sekhar Surapaneni, et al.. (2012). Pharmacokinetic Characterization of Amrubicin Cardiac Safety in an Ex Vivo Human Myocardial Strip Model. I. Amrubicin Accumulates to a Lower Level than Doxorubicin or Epirubicin. Journal of Pharmacology and Experimental Therapeutics. 341(2). 464–473. 9 indexed citations
14.
Salvatorelli, Emanuela, Pierantonio Menna, Mario Lusini, Elvio Covino, & Giorgio Minotti. (2009). Doxorubicinolone Formation and Efflux: A Salvage Pathway against Epirubicin Accumulation in Human Heart. Journal of Pharmacology and Experimental Therapeutics. 329(1). 175–184. 20 indexed citations
15.
Gianni, Luca, Emanuela Salvatorelli, & Giorgio Minotti. (2007). Anthracycline cardiotoxicity in breast cancer patients: synergism with trastuzumab and taxanes. Cardiovascular Toxicology. 7(2). 67–71. 97 indexed citations
16.
Menna, Pierantonio, Emanuela Salvatorelli, Luca Gianni, & Giorgio Minotti. (2007). Anthracycline Cardiotoxicity. Topics in current chemistry. 283. 21–44. 24 indexed citations
17.
Menna, Pierantonio, Giorgio Minotti, & Emanuela Salvatorelli. (2006). In vitro modeling of the structure–activity determinants of anthracycline cardiotoxicity. Cell Biology and Toxicology. 23(1). 49–62. 39 indexed citations
18.
Minotti, Giorgio, Pierantonio Menna, Emanuela Salvatorelli, Gaetano Cairo, & Luca Gianni. (2004). Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity. Pharmacological Reviews. 56(2). 185–229. 3006 indexed citations breakdown →
19.
Cartoni, Antonella, Pierantonio Menna, Emanuela Salvatorelli, et al.. (2004). Oxidative Degradation of Cardiotoxic Anticancer Anthracyclines to Phthalic Acids. Journal of Biological Chemistry. 279(7). 5088–5099. 29 indexed citations
20.
Minotti, Giorgio, Massimo Parlani, Emanuela Salvatorelli, et al.. (2001). Impairment of myocardial contractility by anticancer anthracyclines: role of secondary alcohol metabolites and evidence of reduced toxicity by a novel disaccharide analogue. British Journal of Pharmacology. 134(6). 1271–1278. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pierantonio Menna Breakdown of academic impact, for papers by Srigiridhar Kotamraju Breakdown of academic impact, for papers by Tomáš Šimůnek Breakdown of academic impact, for papers by Eugene A. Konorev Breakdown of academic impact, for papers by Elena Monti Breakdown of academic impact, for papers by Nicholas R. Bachur Breakdown of academic impact, for papers by Jing Lü Breakdown of academic impact, for papers by Karen R. Grotzinger Breakdown of academic impact, for papers by Graziella Pratesi Breakdown of academic impact, for papers by Rosanna Supino
Rankless by CCL
2026